SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel ($INTC) is surging after a strong earnings report, with revenue and EPS exceeding expectations, sparking optimism about its turnaround. Community members are discussing the potential for a short squeeze and future growth, fueled by government investment and new strategic directions. Positive commentary surrounds CEO Lip Bu Tan, with many believing he is steering the company toward a comeback in the semiconductor industry.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending following news of its biometric system deployment at Chicago O'Hare International Airport. Community members are speculating about further airport expansions and potential TSA contracts, contributing to bullish sentiment. Discussions also involve the stock's potential for a short squeeze and comparisons to other AI stocks.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending amidst discussions around meme coins and potential gains, with some community members drawing comparisons to previous rallies of similar assets like Dogecoin and Pepe. Conversations also include speculation about market cycles, potential 'scam' allegations, and whether SHIB can still deliver significant returns. The community is actively debating its future, especially in light of broader crypto market conditions.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending amid speculation and conflicting reports about potential government investment in quantum computing companies, driving high trading volume. Community discussions revolve around the accuracy of news reports and the potential impact of government involvement on the sector. Some traders believe QBTS could benefit significantly due to its position in the quantum optimization market.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is trending amid volatile market conditions, with community members actively discussing dip-buying strategies and potential recovery points. The conversation includes comparisons to other meme coins like SHIB and DOGE, while some traders are exploring new, low market cap opportunities within the memecoin space. Despite recent price drops, some remain optimistic about a potential rebound and long-term growth.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor is trending as the community analyzes recent quarterly earnings and future sales estimates, with some investors seeing a buying opportunity despite revised revenue outlooks. Community members are actively debating the impact of tariffs, consumer spending, and brand growth, especially for HOKA and UGG. Some traders are highlighting technical indicators and historical support levels to evaluate potential price movements.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending as investors digest recent earnings and a drop in gold production, despite beating expectations. The community is discussing the CEO's performance on the earnings call and debating whether the stock's reaction is an overreaction, considering the surge in gold prices. Some traders are weighing the potential for share buybacks and dividend increases, while others consider switching to physical gold.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express strong conviction and highlight its stability, particularly its consistent floor and liquidity depth, despite market volatility. The community frequently references WAGMI alongside other popular meme coins like DOGE, SHIB, and PEPE, suggesting it's viewed as a potential contender in the meme economy. Some community members are discussing the potential for substantial returns due to the strong community and consistent liquidity.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending as investors discuss its potential following Intel's strong earnings, highlighting the increasing demand for AI compute. Community members are weighing in on the recent pullback, with some seeing it as a buying opportunity, while others remain cautious about the broader market volatility. Positive sentiment is fueled by the company's AI cloud infrastructure and partnerships, including its autonomous vehicle subsidiary Avride.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending as investors discuss its potential in the drone and defense sectors, focusing on the company's partnerships and future growth. Community members are weighing in on the recent stock dilution vote and its implications for the company's expansion plans and defense contracts. Bullish sentiment revolves around long-term growth prospects and potential government contracts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Protara Therapeutics Inc. skyrocketed over 100% on Thursday afternoon, reaching levels last seen in January 2022 amid a trading volume over 540 times the daily average.The clinical-stage company unveiled promising results from its ongoing Phase 2 ADVANCED-2 trial for its investigational cell-based therapy, TARA-002.The trial evaluates TARA-002 for high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) in patients with carcinoma in situ (CIS) who are either Bacillus Calmette-Guérin (BCG)-Unresponsive or BCG-Naive. Highlights from the study include:• A complete response (CR) rate of 72% at six months and 70% at any time during the trial.• 100% of patients with CR at three months maintained it through six months.• Two out of three patients maintained a CR at nine months.Adverse events were generally mild, with no discontinuations due to treatment-related side effects. The most common issues, such as flu-like symptoms or bladder irritation, were consistent with responses to bacterial immunotherapy and typically resolved within hours or days.The data will be presented during a poster session at the 25th Annual Meeting of the Society of Urologic Oncology in Dallas, Texas, the company said."We are thrilled with these positive six-month data, which reinforce TARA-002's potential in NMIBC, while offering a compelling product profile for physicians and patients," said Jesse Shefferman, Chief Executive Officer of Protara Therapeutics.&nbsp;"We believe these encouraging data together with our international site expansion will accelerate patient enrollment, and we look forward to reporting initial data from 12-month evaluable patients in mid-2025."<figure class="image"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_05_at_11_12_34_PM_c755be6fcf.png" alt="Screenshot 2024-12-05 at 11.12.34 PM.png" width="1318" height="318"><figcaption>TARA sentiment and message volume on Dec 5 as of 12:30 am ET | source: Stocktwits</figcaption></figure>Retail sentiment for TARA turned ‘extremely bullish’ on Stocktwits, with the ticker trending in the top 10 symbols by Thursday afternoon.&nbsp;<stembedurl>https://stocktwits.com/eXpeditor/message/595247480</stembedurl>Retail chatter on the stock has increased by 2,100% over the past year, with follower count growing by nearly 4%.Protara shares have surged almost 230% year-to-date, significantly outperforming broader market indices.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail chatter on Protara has increased by 2,100% over the past year, with follower count growing by nearly 4%.

Protara Therapeutics Stock Doubles On Promising Bladder Cancer Trial Data: Retail Buzz Spikes

The data will be presented during a poster session at the 25th Annual Meeting of the Society of Urologic Oncology in Dallas, Texas, the company said.

Equity

The data will be presented during a poster session at the 25th Annual Meeting of the Society of Urologic Oncology in Dallas, Texas, the company said.


12 titres de soins de sant  en mouvement lors de la pr -ouverture le 05/04/2024

Gagnants
Le titre Etao International Co (NASDAQ:ETAO) a mont vendredi de 25,61% 3,58 dollars lors de la session pre-market.
Le titre Protara Therapeutics (NASDAQ:TARA) a augment de 21,39% 4,88...

Protara Therapeutics announces $45M private placement financing

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

12 titoli sanitari in movimento, pre-market del 05/04/2024

Titoli in rialzo
Le azioni di Protara Therapeutics (NASDAQ:TARA) hanno fatto segnare +29,35% a 5,20 dollari durante la sessione pre-market di venerd .
Il titolo Etao International Co (NASDAQ:ETAO) ha...

12 acciones de salud en movimiento durante la preapertura del 05/04/2024

Acciones al alza
Etao International Co (NASDAQ:ETAO) experimentaron un repunte del 25,61% para establecerse en los 3,58 d lares durante la sesi n del pre-market del viernes.
Protara Therapeutics...

Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing

Anticipated net proceeds, along with existing cash and cash equivalents, expected to extend cash runway into 2026NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq...

Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition

New development pathway significantly expands addressable patient population for IV Choline ChlorideIV Choline Chloride has the potential to become the first FDA-approved IV formulation of choline...

Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC

TARA-002 demonstrated a complete response rate of 43% at three months in BCG-Unresponsive/Experienced patients in ongoing NMIBC programTARA-002 demonstrated a complete response rate of 63% at three...

Buy Rating on Protara Therapeutics Backed by Promising TARA-002 Clinical Trials and Significant Market Opportunity

In a report released today, Stacy Ku from TD Cowen maintained a Buy rating on Protara Therapeutics (TARA Research Report), with a price target of...

Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Preliminary results from ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS on track for 1H 2024Preliminary data from ADVANCED-2 trial evaluating TARA-002 in NMIBC patients with...

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.

TARA
Protara Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TARA News

TARAProtara Therapeutics Inc